The failure rate of Simparica Trio is 2 to 3 percent with a 97 to 98 success rate.
Simparica Trio for dogs treats dogs with hookworm and roundworm infections in the gut and treats flea and tick infestations.
Simparica Trio is also used to prevent heartworm and lungworm disease in dogs which is caused by blood worms which infect the dogs heart and blood vessels which supply the lungs.
Simparica Trio in dogs may cause neurologic signs such as tremors, unsteadiness and/or seizures in dogs with or without a history of neurologic disorders.
Also simparica trio has not been evaluated in pregnant, breeding or lactating dogs.
A Veterinarian will need to write a prescription for Simparica Trio.
Simparica Trio has been demonstrated safe for dogs as young as eight weeks old and weighing as little as 2.8 lbs.
The generic active ingredient for Simparica is Sarolaner.
A cheaper alternative to Simparica Trio is NexGard SPECTRA.
Simparica Trio can be given to your dog with or without food.
Simparica Trio tablets are palatable and readily consumed by the majority of dogs when offered.
If the Simparica Trio tablet is not taken up voluntarily by the dog it can also be given with food or directly into the mouth.
The tablets should not be divided.